Maggioni C, Cornélissen G, Otsuka K, Halberg F, Consonni D, Nicolini U
University of Milan, Milan, Italy.
Biomed Pharmacother. 2005 Oct;59 Suppl 1(Suppl 1):S86-91. doi: 10.1016/s0753-3322(05)80015-0.
This study aimed at examining any relation between the circadian variation in blood pressure (BP) in human pregnancy and fetal growth. A prospective study included 52 pregnant women monitored during the third trimester of pregnancy. There were 33 uncomplicated pregnancies with normal fetal growth (Group 1) and 19 pregnancies complicated by intrauterine growth retardation (IUGR), confirmed at birth (Group 2). Ten women (five in each group) had pregnancy-induced hypertension. All women were hospitalized and followed a similar daily routine. BP was recorded with an automatic wearable device. Measurements were obtained every 20 min for 24 +/- 1 h. BP profiles were analyzed by conventional statistical methods and by cosinor, involving the least squares fit of cosine curves with an anticipated period (24 h) to the data. BP parameters, fetal outcome, demographic and obstetric characteristics were compared between the two groups. Logistic regression and multivariate analyses were used to assess factors putatively associated with fetal outcome. The circadian amplitude of diastolic BP was found to be larger in normotensive women with IUGR. As gauged by odds ratios (OR), the circadian amplitude of diastolic BP (OR = 1.7, 95% CI: 1.1-2.8; P = 0.03) and hematocrit (OR = 1.4, 95% CI: 1.0-1.9; P = 0.04) were the only variables positively and independently associated with IUGR. In the presence of maternal hypertension, the circadian amplitude of systolic BP was negatively associated with IUGR (OR = 0.7, 95% CI: 0.5-1.0; P = 0.03). A larger circadian variation in diastolic BP, rather than a difference in the mean value of systolic or diastolic BP, was found to be statistically significantly associated with IUGR. This study adds another condition in which the circadian BP amplitude constitutes a harbinger of elevated risk, apart from an association with a shortened lifespan in the absence or presence of malignant hypertension and with an increased risk of stroke and nephropathy reported earlier.
本研究旨在探讨人类孕期血压(BP)的昼夜变化与胎儿生长之间的关系。一项前瞻性研究纳入了52名在妊娠晚期接受监测的孕妇。其中33例为胎儿生长正常的无并发症妊娠(第1组),19例为出生时确诊的合并宫内生长受限(IUGR)的妊娠(第2组)。10名女性(每组5名)患有妊娠期高血压。所有女性均住院并遵循相似的日常作息。使用自动可穿戴设备记录血压。在24±1小时内每20分钟进行一次测量。通过传统统计方法和余弦分析法分析血压曲线,即将预期周期(24小时)的余弦曲线与数据进行最小二乘拟合。比较两组之间的血压参数、胎儿结局、人口统计学和产科特征。采用逻辑回归和多变量分析来评估可能与胎儿结局相关的因素。发现IUGR的血压正常女性的舒张压昼夜振幅更大。以优势比(OR)衡量,舒张压的昼夜振幅(OR = 1.7,95%CI:1.1 - 2.8;P = 0.03)和血细胞比容(OR = 1.4,95%CI:1.0 - 1.9;P = 0.04)是与IUGR呈正相关且独立相关的唯一变量。在存在母体高血压的情况下,收缩压的昼夜振幅与IUGR呈负相关(OR = 0.7,95%CI:0.5 - 1.0;P = 0.03)。发现舒张压的昼夜变化较大,而非收缩压或舒张压的平均值差异,与IUGR在统计学上显著相关。除了与无或有恶性高血压时的寿命缩短以及先前报道的中风和肾病风险增加有关外,本研究还增加了另一种情况,即昼夜血压振幅构成高风险的先兆。